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Abstract
Background: Plasmodium falciparum the main causative agent of malaria is an important public health vector. With the use
of PCR, its genetic diversity has been extensively studied with dearth information from Nigeria.
Methods: In this study, 100 P. falciparum strains merozoite surface protein 1( msp-1), merozoite surface protein 2 (msp-2)
and Glutamate rich protein (Glurp) from Ogun State General Hospitals were characterized. The genetic diversity of  P.
falciparum isolates was analyzed by restriction fragment length polymorphism following gel electrophoresis of DNA products
from nested polymerase chain reactions (PCR) of their respective allelic families KI, MAD 20, RO33 (MSP-1);FC27, 3D7
(MSP-2) and Glutamate rich protein respectively.
Results: Majority of the patients showed monoclonal infections while multiplicity of the infection for msp-1 and msp-2 were
1.1 and 1.2 respectively. The estimated number of  genotypes was 8 msp-1 (4 KI; 3 MAD; 1 RO33) and 6 msp-2 (3 FC27;
3 3D7). 80% of  the isolates coded for Glurp with allelic size ranged between 700 and 900 bp.
Conclusion: The allelic distributions however were similar to those previously reported in other endemic malaria countries.
Future studies will be designed to include other malaria endemic regions of Nigeria such as the oil exploration regions.
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Introduction
Malaria remains an important public health concern
in countries where transmission occurs regularly; 90%
of the global burden of malaria occurs in Africa,
south of Sahara1,2. Each year an estimated 300 to
650 million clinical cases of malaria occur, making it
one of the most common infectious diseases
worldwide3. Young children, pregnant women, and
non-immune visitors to malarious areas are at
greatest risk of  severe or fatal illness4. Information
on the nature and extent of genetic diversity within
P falciparum is essential in understanding the
mechanism underlying the pathology of  malaria, the
acquisition of  immunity, the spread of  drug resistance,
the condition of transmission and the development
of vaccines against the parasite5,6,7. However,
extensive genetic diversity in natural parasite
populations is a major obstacle for the development
of an effective vaccine against the human malaria
parasite, since antigenic diversity limits the efficacy
of acquired protective immunity to malaria4.
Molecular techniques have facilitated the studies on
genetic diversity of Plasmodium species particularly
from field isolates collected directly from patients.
Merozoite surface Proteins 1 and 2 (MSP1 and
MSP2) are among the membrane proteins
characterized to date that are present on the surface
of P falciparum merozoites8,9. They have been shown
harboring antigenic and specific antibodies directed
against MSP-2 epitopes that inhibit merozoite
invasion of erythrocytes during in vitro experiments10.
Restriction fragment length polymorphism and
polymerase chain reaction (PCR) genotyping using
the three gene loci (MSP1, MSP2 and Glurp) have
been used to distinguish treatment failures from newly
acquired infections11.
It has been established that the msp-1 gene is
divided into 17 blocks, based on analysis of sequence
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diversity: seven highly variable blocks are interspersed
with five conserved and five semi-conserved regions.
Block 2 of the msp-1 gene appears to be subjected
to rapid intragenic recombination, and so, is highly
polymorphic4. The msp-2 gene, also known as
merozoite surface antigen (msa-2) gene, codes for a
merozoite surface polymorphic glycoprotein that has
been widely studied as one of the major vaccine
candidates.The sequencing of  DNA has shown that
a single copy of  msp-2 gene has conserved N- and
C- terminal domains (blocks 1 and 5), two non-
repetitive variable regions (blocks 2 and 4), and a
polymorphic central region (block 3) containing
variable numbers of tandem repeats, which also vary
in sequence and length 12,13,14. Genes in which
polymorphism has arisen through intragenic
recombination in repetitive segments are
characterized by repeat motifs with length variability
differing between strains.
Two highly polymorphic and widely used
markers are msp-1 and msp-2 and the large allelic
polymorphism has been reported in the block 2 of
the msp-1 gene and the central repetitive domain
(block3) of the msp-2 gene. Families differing in
nucleotide sequences and in number of repetitive
sequences (length variation) were used for genotyping
purposes. In msp-1 (block 2) three distinct allelic
families have been described: K1, MAD20 and RO33
while msp-2 has two distinct families, 3D7 and FC27.
Studies on genetic diversity, differentiation
of the different strains within a Plasmodium species
and presence of multiple parasite strains in individual
host have been reported from different regions of
the globe5,11,14,15,16,17. However, limited reports are
available on the genetic diversity existing among P.
falciparum population of Nigeria. In this report,
polymorphic markers in P. falciparum isolates were
used to examine genetic diversity and complexity
of parasite populations in patients with
uncomplicated malaria infections in Ogun State,
South Western Nigeria.
Methods
Study setting
Ogun State is in the transitional zone between the
tropical rain forest and derived savannah zone in the
southwest, Nigeria. The area experiences two seasons,
the dry season (November to March) and the wet
season (April to October). The annual temperature
range from 22.8 oC to 34.9 oC and the mean annual
rainfall is about 107.3 mm. Malaria is present
throughout the year with a marked increase during
the raining season19. The State was divided into 4
zones for sample collection. This was based on
geopolitical and health zoning. The 4 zones are Sango
– Ota (Yewa), Abeokuta (Egba), Ijebu Ode (Ijebu)
and Sagamu (Remo).
Sample collection
A total of 4066 subjects comprising of 1839 males
and 2227 females presenting with malaria in 4
different health districts of Ogun State were sampled
for malaria screening. Safety procedures were
adopted in the collection of finger-prick blood
samples by swabbing the area to be sampled with
70% alcohol and allowed to dry before collection.
100 subjects were included in this pilot study for
molecular characterization of P falciparum. The criteria
for inclusion in the study were fever or a history of
fever in the 24 - 48 hours preceding presentation;
parasite density of  more than 2,000 asexual forms
per microliter of  blood confirmed by microscopy;
no history of antimalarial drug ingestion two weeks
preceding presentation. The bleeding (venepuncture)
was done in the hospitals by clinicians/Medical
laboratory scientists and blood was transported to
the laboratory in heparin bottles at 4 0C. Peripheral
blood was collected on 1.5 x 7.0-cm strips of
Whatman (Brentford, United Kingdom) 3 MM filter
paper and in heparinised bottles. The strips were then
air-dried and kept in plastic bags until use.
Ethical consideration
Scientific and Ethical permit/clearance was obtained
from the Nigerian Institute of Medical Research -
Institutional Review Board (NIMR-IRB) and
Covenant University Ethics Committee. The Ogun
State Ministry of health (Hospitals Management
Board) was also informed before this research was
carried out. Written informed consent was obtained
from patients prior to recruitment into this study.
Consent for the children was provided by the
parents/guardians while some of the children
participants provided the assents by nodding and
thumb printing.
Microscopic examination
Thick and thin films of the blood samples were
prepared. Thin films were fixed with methanol and
all films were stained with 3% Giemsa stain of pH
7.0 for 30 min as recommended by Cheesbrough20.
Blood films were examined microscopically using
100X (oil immersion) objectives as described by
Cheesbrough20. The thick films were used to
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determine the parasite densities while thin films were
used to identify the parasite species and infective
stages. Parasite density per microliter of  blood was
estimated from the thick film by taking the number
of leucocytes per microliter of blood as 8,000 and
expressed as follows:
Parasite density/uL =  Parasite count x 800
No of WBC counted
DNA extraction and Molecular analyses
DNA was extracted from patient blood samples
on 3MM Whatman filter paper (Brentford, United
Kingdom) using the QiaAmp DNA Blood Minikit
Blood and Body Fluid Spin Protocol (Qiagen,
Valencia, CA). Molecular Genotyping of  isolates
using merozoite surface proteins 1 and 2 (msp1 and
msp2) and Glutamate rich protein (Glurp) primers
and PCR protocols were followed as previously
described by Snounou et al9 for family specific allele
analysis of  msp-1 (block 2), msp-2 (block 3) and Glurp.
PCR amplification was performed on thermal cycler
(Perkin Elmer 9700/2400, UK) in a final volume
of 20 /μl. The PCR products were visualized by
UV transillumination at 302 nm on gel
documentation system (Syngenta, USA) after
electrophoresis on 2% agarose gel (Promega/
Boehringer) using 0.5 × TBE buffer at 80–100 volts.
Allele sizes were calculated using Gene tool
programme.
Data interpretation
Based on the visual inspection of amplified fragments
separated by agarose gel electrophoresis, alleles were
classified according to the number of fragments,
size of each fragment, and allelic family to which
each fragment belongs. Fragment sizes were
estimated by comparing with molecular size
standards. Positive controls were set up using
characterized P. falciparum isolates. To understand the
identity of Nigerian isolates with respect to isolates
of other regions, sequence data available in public
domains were downloaded for allelic families of
msp-1&2 and details are given below;
Thailand (K1-M77730, MAD20-M77722, R033-
AAA29684, 3D7- U91676),
Vietnam (K1-AF509651, MAD20-AF509653&94,
FC27-AF104696, 3D7-AF104693),
Tanzania (K1-AF061134, FC27-AY532386),
Brazil (K1-AF509714, MAD20-AY714585,
FC27-DQ115973, 3D7-AF177389),
China (MAD20-AF251345),
Sudan (MAD20-AF034635),
Iran (MAD20-AY138509, R033-AY138507, FC27-
DQ338451),
Indonesia (K1-AF191061, R033-AAF18431),
Western Africa (R033-PFAMSA1),
Kenya (R033-AAM21583),
Ghana (FC27-AF329577), PNG(FC27-AF329579),
Gambia (FC27-U91668, 3D7- U91665)
Nigeria (3D7-AF148224)
Statistical analysis
Statistical analysis was performed using Stat View
5.0.1 (SAS Institute Inc., Cary, NC). Statistical
significance was based on á level of 0.05.
Results
One hundred P. falciparum isolates analyzed during
the study have demonstrated highly diverse nature
of field isolates in respect of msp-1 (block 2) and
msp-2 (central repeat region, block3).
Plate 1: DNA bands of  P. falciparum MSP1
MAD20 on gel
Plate 2: DNA bands of  P. falciparum MSP1K1
on gel
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Plate 3: DNA bands of  P. falciparum MSP1
RO33 on gel
Plate 4: DNA bands of  P. falciparum MSP2 3D7
on gel
Plate 5: DNA bands of  P. falciparum Merozoite
surface protein FC27 on gel
Plate  6:  DNA bands of  P. falciparum Glutamate
rich protein
As an estimate of multiclonality of infection, the minimal
number of  P. falciparum strains in each individual was
determined by assessing the number of  alleles of
the genes encoding merozoite surface protein 1
(MSP-1) and MSP-2 families (table 1). The MSP-1
and MSP-2 alleles were defined by gene family-
specific PCR assays and analysis of the resulting length
polymorphisms of the PCR products
One hundred P. falciparum isolates analyzed
during the study have demonstrated highly diverse
nature of field isolates in respect of msp-1 (block 2)
and msp-2 (central repeat region, block3). All the three
reported families of msp-1(K1, MAD20 and RO33)
as shown on plates 1-3 and two of msp-2 (FC27
and 3D7), were observed among the isolates (Plates
5 and 6). DNA bands of  the P. falciparum  MSPP2
3D& are shown in plate 4. Proportion of isolates
with K1 family was 68 % with 4 alleles in the range
of  100 to 300 bp. Proportion of  isolates with
MAD20 family was 40 % and a total of 3 alleles
were observed within 100 to 300 bp. RO33
proportion was 20 % and the family was observed
to be monomorphic with an allele size of  200 bp.
Observed proportions, numbers and size range of
alleles among the isolates are given in table 1.
In msp-2, the reported families FC27 and 3D7
were observed among the isolates (Table 2).
Proportion of FC27 family was 76 % and that of
3D7 was 56 %. Proportional prevalence of FC27
and 3D7 families was significantly different (chi
square = 16.5, P = 0.002). Three alleles of FC27 in
the range of 300–500 bp and 3 alleles of 3D7 in the
range of  450–600 bp were observed. Proportion
of multiclonal isolates (multiple infection) is given in
table 2 and multiplicity of the infection (MOI) was
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estimated by dividing the total number of fragments
detected in the individual system by the number of
samples positive in the particular system (either msp-
1 or msp-2). Eighty percent of the isolates harboured
the glutamate rich protein with allelic size ranging
from 700-900 bp
Table 1: Genetic diversity of  Plasmodium falciparum isolates from Ogun State, South
Western Nigeria
Loci No. positive    No. of distinct    Sizes of alleles MOI
by PCR (%)     alleles (bp)
MSP-1
K1 68 (68)       4 100-300
MAD20 40 (40)       3 100-300 2.1
RO33 20 (20)       1 200
MSP-2
3D7 76 (76)              3 450-600
FC27 56 (56)      3 300-500 2.2
GLURP 80 (80)      5 700-900 1.3
* bp _ base pairs; MSP _ merozoite surface protein; GLURP _ glutamate-rich protein. MOI
= Multiplicity of Infection
Table 2: Zone wise genetic diversity of  P. falciparum from Ogun State, South western  Nigeria
Zone No of Isolates                                     MSP 1        MSP 2
           K1 (%)        MAD20 (%)     RO33 (%)  3D7 (%)    FC27 (%)  Glurp (%)
Ijebu                 20           14 (20.6)          9 (22.5)         6 (30)     16 (21.1)     13 (23.2)        16 (20)
Yewa 43 31 (45.6)    21 (52.5)         8 (40)        38 (50)       18 (32.1)        33 (41.3)
Egba        25                 15 (22.1)         7 (17.5)      4 (20)     12 (15.8)     18 (32.1)       21(26.3)
Remo 12 8 (11.8)     3 (7.5)         2 (10)     10 (13.2) 7 (12.5)       10 (12.5)
Total 100 68 (100)        40 (100)         20 (100)     76 (100)      56 (100)         80 (100)
Discussion
In this study, polymorphic markers in P. falciparum
isolates were used to examine genetic diversity and
complexity of parasite populations in patients with
uncomplicated malaria infections in Ogun State,
South Western Nigeria. It bridges an important gap
in the understanding of the molecular characteristics
of the parasite population in Ogun State. As limited
reports are available on the genetic diversity among
the P falciparum population of Nigeria, this pilot study
evaluated the extent of genetic diversity in the field
isolates of  P. falciparum in South Western Nigeria.
The Merozoite Surface Protein1 (MSP-1)
and Merozoite Surface Protein2 (MSP-2) are highly
polymorphic markers and the large allelic
polymorphism has been reported in the block 2 of
the msp-1 gene and the central repetitive domain
(block3) of the msp-2 gene. Families differing in
nucleotide sequences and in number of repetitive
sequences (length variation) were used for genotyping
purposes.
The population structure of  P. falciparum
isolates analyzed with the polymorphic markers
(MSP-1), MSP-2, and Glutamate Rich Protein
(GLURP) in this study showed extensive diversity in
parasite populations in the four zones in Ogun State,
South Western Nigeria. The MSP-1, MSP-2, and
GLURP markers showed 8, 6, and 5 allelic families
respectively (Table 1). This diversity of  the P. falciparum
population in South Western Nigeria is reflected in
the complexity of  parasite populations in the samples.
A catalog of genetically distinct parasite populations
co-infecting those infected with malaria, based on
PCR amplification of the Glutamate rich protein
(Glurp), Merozoite Surface Protein 1 (MSP-1), and
Merozoite surface Protein 2 (MSP-2) markers
showed that multiplicity of infection was common.
Multiclonality of infections has been shown to be a
common feature in most malaria-endemic
areas20,21,22.23. Epidemiologic data from some study
sites in Africa suggest that the multiplicity of  P.
falciparum infection may be directly related to the
intensity of transmission21,22,23.
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The multiplicity of  infection observed in this
study is high, compared to the ones observed in
similar studies from other regions 8,9,17,18,20,21. This
suggests that the intensity of  transmission of  malaria
in this region is high. This multiplicity of infections
may also have important implications for the
epidemiology of  drug-resistant P. falciparum malaria
and the outcome of  treatment in patients. The initial
presence of several parasite populations with
different drug response profiles would result in
elimination of drug sensitive populations and
selection of  resistant parasites.
The findings in this study are in agreement
with previous studies involving asymptomatic carriers
and symptomatic patients in holoendemic areas, both
in the complexity of population structure and
multiplicity of parasites in human hosts5,7,8,9. All the
MSP 1 and MSP2 families were represented in each
of  the four zones in Ogun State, South Western
Nigeria where samples were collected. Genotyping
of these samples showed that the allelic families of
MSP-1 and MSP-2 were often represented in parasite
DNA derived from a single patient, indicating a
polyclonal infection. Specifically, three allelic families
of MSP-1 and two of MSP-2 were assessed
respectively. Alleles were classified according to the
size of  PCR fragments. Prevalence of  identical allelic
composition of alleles in the four study areas of the
Ogun State, Nigeria suggests that there is a
considerable amount of  gene flow between the P.
falciparum populations of  different zones.
Conclusion
The present study shows that field isolates of Ogun
State, South Western Nigeria are highly diverse in
respect of msp-1 (block 2) and msp-2 (central repeat
region, block 3) and glutamate rich protein. This pilot
study has shown the diversity and complexity of  P.
falciparum populations in South Western, Nigeria. The
MSP-2 marker appears to be the most reliable genetic
marker to evaluate diversity and complexity of  P.
falciparum infections8,23. This approach in addition to
other molecular methods may be useful as part of
the surveillance program for monitoring drug-
resistant malaria infections.
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